Naoero vs Qatar: New cases tested for RR-/MDR-TB
Naoero
100.0%
in 2023
Qatar
100.0%
in 2024
Naoero rank
1st
Qatar rank
1st
New cases tested for RR-/MDR-TB over time
- Naoero
- Qatar
How they compare
Naoero currently reports 100.0% against 100.0% in Qatar, a difference of 0.0%.
Across all 11 years both countries report, Qatar has been ahead every year.
Naoero ranks 1st and Qatar ranks 1st of 192 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Naoero | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 100.0% | 100.0% | Qatar |
| 2010s | 0.0% | 59.4% | 59.4% | Qatar |
| 2020s | 75.0% | 100.0% | 25.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Naoero or Qatar?
- Naoero, at 100.0% against 100.0% in Qatar as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Naoero and Qatar?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Qatar?
- 11 years are reported by both, from 2009 to 2023.
- How do Naoero and Qatar rank globally for new cases tested for rr-/mdr-tb?
- Naoero ranks 1st and Qatar ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.